Intensifying Antiretroviral Therapy With Raltegravir and Maraviroc During Early Human Immunodeficiency Virus (HIV) Infection Does Not Accelerate HIV Reservoir Reduction

Background. Persistent human immunodeficiency virus (HIV) within the CD4(+) T-cell reservoir is an obstacle to eradication. We hypothesized that adding raltegravir and maraviroc to standard combination antiretroviral therapy (cART) during early HIV infection could substantially reduce viral reservoi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Ostrowski, Mario, Benko, Erika, Yue, Feng Yun, Kim, Connie J., Huibner, Sanja, Lee, Terry, Singer, Joel, Pankovich, Jim, Laeyendecker, Oliver, Kaul, Rupert, Kandel, Gabor, Kovacs, Colin
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
Major Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4621663/
https://ncbi.nlm.nih.gov/pubmed/26512359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofv138
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados